Please find attached the corrigendum of AGM notice.

Date: 20th August, 2026 The Deputy General Manager, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. BSE Scrip Code: 542934 Subject: Corrigendum to the notice of the Annual General Meeting of Company Dear Sir/Madam, In continuation of our intimation dated 6th August, 2026, we hereby submit the Corrigendum to the Notice of the Annual General Meeting (“AGM”) of the Company, which is scheduled to be held on Tuesday, 1st September, 2026, at 04:00 P.M. (IST) at the Registered Office of the Company situated at 323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai-400019, Maharashtra, India. Further, the aforesaid Corrigendum has also been sent to the shareholders vide email dated 20th August, 2026, through MUFG Intime India Private Limited (formerly Link Intime India Private Limited), and also been made available on the website of the Stock Exchange, i.e., BSE Limited. A copy of the said corrigendum to the AGM Notice is also available on the website of the Company at https://cbcpharma.com/invester/#list_preferential All other contents and items of the AGM Notice, along with the Explanatory Statement thereto, save and except as modified or supplemented by the Corrigendum, shall remain unchanged. Kindly take the above information on your records. Your faithfully Thank you FOR CHANDRA BHAGAT PHARMA LIMITED HEMANT C BHAGAT MANAGING DIRECTOR DIN: 00233530 CORRIGENDUM TO THE NOTICE OF THE ANNUAL GENERAL MEETING (“AGM”) Chandra Bhagat Pharma Limited (hereinafter referred to as the “Company”) has issued and circulated the Notice of the Annual General Meeting (“AGM”) convening the AGM of the members of the Company, which is scheduled to be held on Tuesday, 1st September, 2026, at 04:00 P.M. (IST) at the Registered Office of the Company situated at 323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai – 400019, Maharashtra, India. The Notice of the AGM was dispatched to the shareholders of the Company on Thursday, 6th August, 2026, in due compliance with the provisions of the Companies Act, 2013, the SEBI Regulations and the relevant rules made thereunder. Pursuant to the requirements of Regulation 28(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the Company had filed an application with BSE Limited (“Stock Exchange”) for obtaining in-principle approval for the proposed issuance of 66,00,000 (Sixty-Six Lakhs) Convertible Warrants (“Warrants”) of the Company on a preferential basis (“Preferential Issue”), as detailed in Item No. 4 of the Explanatory Statement to the Notice of the AGM. The Stock Exchange has requested the Company to provide the exact web link to the compliance certificate issued by M/s. Dilip Swarnkar & Associates, Practicing Company Secretary, certifying that the Preferential Allotment is being made in accordance with the requirements contained in the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, with respect to the proposed Preferential Issue. Accordingly, the Company is issuing this Corrigendum to the Notice of the AGM. This Corrigendum (“Corrigendum”) is being issued to inform the members of the Company about the exact web link at https://cbcpharma.com/wp-content/uploads/2026/08/CS-Certificate.pdf pertaining to sub-item No. 19 under Item No. 4 of the Explanatory Statement to the Notice of the AGM. Kindly read the sub-item No. 19 under Item No. 4 of the Explanatory Statement as follow: The certificate from, M/S. Dilip Swarnkar & Associates, the Practicing Company Secretary, certifying that the Preferential Allotment is being made in accordance with the requirements contained in the SEBI (ICDR) Regulations, is hosted on the Company’s website and is accessible at link: https://cbcpharma.com/wp-content/uploads/2026/08/CS-Certificate.pdf Corrigendum to the Notice of the AGM shall form an integral part of the Notice of the AGM already circulated to the shareholders of the Company and, from the date hereof, the Notice of the AGM shall be read in conjunction with this Corrigendum. Further, this Corrigendum has also been sent to the shareholders by email dated 20th August, 2026 through MUFG Intime India Private Limited (formerly Link Intime India Private Limited) and has also been made available on the website of the Stock Exchange, i.e., BSE Limited. All other contents and items of the Notice of the AGM, along with the Explanatory Statement thereto, save and except as modified or supplemented by this Corrigendum, shall remain unchanged. A copy of the said Corrigendum to the Notice of the AGM is also available on the website of the Company at https://cbcpharma.com/invester/#list_preferential Further, M/s. Amit Dharmani & Associates, Practicing Company Secretaries, will act as the Scrutinizer for scrutinizing the voting process and issuing the Scrutinizer’s Report in respect of the voting on the Notice of the AGM and this Corrigendum. By Order of the Board of Directors For Chandra Bhagat Pharma Limited Sd/- Hemant C Bhagat Managing Director DIN: 00233530 Place: Mumbai Date: 20.08.2026